Alej Svobody 80
323 00 Plzeň
Head of the clinic: Doc. MUDr. Zdenek Rokyta. CSc.
Coordinator of study: MUDr. Vladimir Kokesh
The duration of the study: 28.5.2009 - 22.3.2010
The number of patients: 120 patients with gynecological malignant tumor.
The division and the number of patients according to the daily dosage:
The division of patients according to the diagnosis:
|C 52 Malignant tumor of the vagina||1 patient|
|C 53 Malignant tumor of the cervix||33 patients|
|C 54 Malignant tumor of the uterus||46 patients|
|C 56 Malignant tumor of the ovary||37 patients|
|C 57 Malignant tumor of oviduct||3 patients|
|In total||120 patients|
The absolute majority of patients positively estimated the feelings and the efficiency of the preparation Penoxal.
Any unwanted side effects and an allergic reaction are registered. The objective lab results after the treatment have stabilized. Some patients stated the improvment of the immune situation concerning resistance to viral diseases. In the process of receiving the preparation the patients felt well. At one patient the digestive problems disappeared.
Unwanted symptoms in using the preparation (Penoxal):
Both of the two mentioned patients diagnosed relapse or disease progression had highly aggressive and risky histological type of tumor diseases.
The last 117 patients mentioned above were not identified any negative sensations or symptoms. All these patients were absolutely satisfied with this preparation and positively estimated the effect of the tested preparation Penoxal. The group of patients was not completely consistent because the period of taking the preparation wasn't so long.
|MUDr. Vladimir Kokesh
The study coordinator
|Doc MUDr. Zdenek Rokyta CSc.
Head of the Clinic